Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Clean interim safety review of RhoVac's clinical phase IIb study in prostate cancer
2021-07-09 21:38
ABL Bio Announces Publication of Preclinical Data Demonstrating Safety and Efficacy of ABL503/TJ-L14B, a Novel Anti-PD-L1 X 4-1BB Bispecific Antibody
2021-07-09 21:00
I-Mab Expands Emerging Portfolio of Next Generation Novel Oncology Therapeutics Through Cutting-Edge mRNA and AI Technology Platforms
2021-07-09 20:00
Alzheimer's Disease Researchers Release Free Memory Tracking App
2021-07-09 18:00
Sequanta and Mission Bio announce strategic partnership
2021-07-09 15:44
Innovent Announces NMPA Acceptance of New Drug Application for the FGFR1/2/3 Inhibitor (Pemigatinib) for the Treatment of Adults with Previously Treated, Unresectable Locally Advanced or Metastatic Cholangiocarcinoma with a FGFR2 Fusion or Rearrangement
2021-07-09 08:00
Vaniam Group LLC announces European and International expansion with addition of new global agency, Vaniam Group Global Ltd
2021-07-09 06:50
New Research Highlights Need for Health-Systems Approach to Vision Care
2021-07-09 03:14
Alpha Tau and Healthcare Capital Corp. to Combine and Create A Publicly Traded Company Focused on Transforming the Treatment of Solid Tumors Through the Precision Delivery of Alpha Radiation
2021-07-08 21:13
Yushangmei seeks to establish partnership with a new target company
2021-07-08 19:29
COVID pandemic heightens a lack of confidence amongst the public about which medicines to take and how to use them
2021-07-08 16:00
Nippon Express (India) Newly Acquires GDP Certification at Three Locations
2021-07-08 15:00
COVID-19: Doctor's certificates for antigen self-tests now offered online worldwide by DrAnsay.com
2021-07-08 13:55
BioShin Expands Senior Leadership Team: Sarah Lu Joins BioShin as Chief Medical Officer, Mary Ma Joins BioShin as Chief Commercial Officer
2021-07-08 12:01
Just 5 minutes: Game-changing PCR to complete nucleic acid amplification, Si-Gene Biotech help out against COVID 19
2021-07-08 11:28
BeatO raises USD 5.7 million in funding led by W Health Ventures
2021-07-08 08:30
CStone announces updated results for AYVAKIT(R) (avapritinib) in Chinese patients with advanced GIST at ESMO World Congress on Gastrointestinal Cancer 2021
2021-07-08 08:05
Cambridge Isotope Labs Announces the First Commercially Available Quantum-Grade Gas, 12C Methane QG-Alpha™ for High-Performance Nitrogen-Vacancy Center Diamonds
2021-07-08 03:24
Otsuka Signs Three-Year Collaboration with Holmusk to Enhance Digital Health and Data Analytics for Global Behavioral Health Programs
2021-07-08 00:56
Ortho Clinical Diagnostics Announces Partnership With Thermo Fisher Scientific
2021-07-07 21:00
1
373
374
375
376
377
896